世界の周産期感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Perinatal Infections Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4682
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、周産期感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗ウイルス剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・周産期感染症治療の市場動向
・企業の競争状況、市場シェア
・周産期感染症治療の種類別市場規模と予測2016-2027（抗生物質、抗ウイルス剤）
・周産期感染症治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・周産期感染症治療の北米市場規模2016-2027（アメリカ、カナダ）
・周産期感染症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・周産期感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・周産期感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・周産期感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amneal Pharmaceuticals、Arbor Pharmaceuticals、Par Pharmaceutical、Mylan、GSK、Novartis、Sun Pharmaceutical、Teva Pharmaceutical、Hikma Pharmaceuticals、ViiV Healthcare）
・結論

Perinatal infections include bacterial or viral illnesses that can be passed from a mother to her baby either while the baby is still in the uterus or during the delivery process. Maternal infection can, in some cases, cause complications at birth.

Market Analysis and Insights: Global Perinatal Infections Treatment Market
The global Perinatal Infections Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Perinatal Infections Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Perinatal Infections Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Perinatal Infections Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Perinatal Infections Treatment market.

Global Perinatal Infections Treatment Scope and Market Size
Perinatal Infections Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Perinatal Infections Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibiotics
Antiviral

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amneal Pharmaceuticals
Arbor Pharmaceuticals
Par Pharmaceutical
Mylan
GSK
Novartis
Sun Pharmaceutical
Teva Pharmaceutical
Hikma Pharmaceuticals
ViiV Healthcare

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Perinatal Infections Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Antiviral
1.3 Market by Application
1.3.1 Global Perinatal Infections Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Perinatal Infections Treatment Market Perspective (2016-2027)
2.2 Perinatal Infections Treatment Growth Trends by Regions
2.2.1 Perinatal Infections Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Perinatal Infections Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Perinatal Infections Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Perinatal Infections Treatment Industry Dynamic
2.3.1 Perinatal Infections Treatment Market Trends
2.3.2 Perinatal Infections Treatment Market Drivers
2.3.3 Perinatal Infections Treatment Market Challenges
2.3.4 Perinatal Infections Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Perinatal Infections Treatment Players by Revenue
3.1.1 Global Top Perinatal Infections Treatment Players by Revenue (2016-2021)
3.1.2 Global Perinatal Infections Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Perinatal Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Perinatal Infections Treatment Revenue
3.4 Global Perinatal Infections Treatment Market Concentration Ratio
3.4.1 Global Perinatal Infections Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Perinatal Infections Treatment Revenue in 2020
3.5 Perinatal Infections Treatment Key Players Head office and Area Served
3.6 Key Players Perinatal Infections Treatment Product Solution and Service
3.7 Date of Enter into Perinatal Infections Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Perinatal Infections Treatment Breakdown Data by Type
4.1 Global Perinatal Infections Treatment Historic Market Size by Type (2016-2021)
4.2 Global Perinatal Infections Treatment Forecasted Market Size by Type (2022-2027)

5 Perinatal Infections Treatment Breakdown Data by Application
5.1 Global Perinatal Infections Treatment Historic Market Size by Application (2016-2021)
5.2 Global Perinatal Infections Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Perinatal Infections Treatment Market Size (2016-2027)
6.2 North America Perinatal Infections Treatment Market Size by Type
6.2.1 North America Perinatal Infections Treatment Market Size by Type (2016-2021)
6.2.2 North America Perinatal Infections Treatment Market Size by Type (2022-2027)
6.2.3 North America Perinatal Infections Treatment Market Size by Type (2016-2027)
6.3 North America Perinatal Infections Treatment Market Size by Application
6.3.1 North America Perinatal Infections Treatment Market Size by Application (2016-2021)
6.3.2 North America Perinatal Infections Treatment Market Size by Application (2022-2027)
6.3.3 North America Perinatal Infections Treatment Market Size by Application (2016-2027)
6.4 North America Perinatal Infections Treatment Market Size by Country
6.4.1 North America Perinatal Infections Treatment Market Size by Country (2016-2021)
6.4.2 North America Perinatal Infections Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Perinatal Infections Treatment Market Size (2016-2027)
7.2 Europe Perinatal Infections Treatment Market Size by Type
7.2.1 Europe Perinatal Infections Treatment Market Size by Type (2016-2021)
7.2.2 Europe Perinatal Infections Treatment Market Size by Type (2022-2027)
7.2.3 Europe Perinatal Infections Treatment Market Size by Type (2016-2027)
7.3 Europe Perinatal Infections Treatment Market Size by Application
7.3.1 Europe Perinatal Infections Treatment Market Size by Application (2016-2021)
7.3.2 Europe Perinatal Infections Treatment Market Size by Application (2022-2027)
7.3.3 Europe Perinatal Infections Treatment Market Size by Application (2016-2027)
7.4 Europe Perinatal Infections Treatment Market Size by Country
7.4.1 Europe Perinatal Infections Treatment Market Size by Country (2016-2021)
7.4.2 Europe Perinatal Infections Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Perinatal Infections Treatment Market Size (2016-2027)
8.2 Asia-Pacific Perinatal Infections Treatment Market Size by Type
8.2.1 Asia-Pacific Perinatal Infections Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Perinatal Infections Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Perinatal Infections Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Perinatal Infections Treatment Market Size by Application
8.3.1 Asia-Pacific Perinatal Infections Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Perinatal Infections Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Perinatal Infections Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Perinatal Infections Treatment Market Size by Region
8.4.1 Asia-Pacific Perinatal Infections Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Perinatal Infections Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Perinatal Infections Treatment Market Size (2016-2027)
9.2 Latin America Perinatal Infections Treatment Market Size by Type
9.2.1 Latin America Perinatal Infections Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Perinatal Infections Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Perinatal Infections Treatment Market Size by Type (2016-2027)
9.3 Latin America Perinatal Infections Treatment Market Size by Application
9.3.1 Latin America Perinatal Infections Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Perinatal Infections Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Perinatal Infections Treatment Market Size by Application (2016-2027)
9.4 Latin America Perinatal Infections Treatment Market Size by Country
9.4.1 Latin America Perinatal Infections Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Perinatal Infections Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Perinatal Infections Treatment Market Size (2016-2027)
10.2 Middle East & Africa Perinatal Infections Treatment Market Size by Type
10.2.1 Middle East & Africa Perinatal Infections Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Perinatal Infections Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Perinatal Infections Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Perinatal Infections Treatment Market Size by Application
10.3.1 Middle East & Africa Perinatal Infections Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Perinatal Infections Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Perinatal Infections Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Perinatal Infections Treatment Market Size by Country
10.4.1 Middle East & Africa Perinatal Infections Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Perinatal Infections Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amneal Pharmaceuticals
11.1.1 Amneal Pharmaceuticals Company Details
11.1.2 Amneal Pharmaceuticals Business Overview
11.1.3 Amneal Pharmaceuticals Perinatal Infections Treatment Introduction
11.1.4 Amneal Pharmaceuticals Revenue in Perinatal Infections Treatment Business (2016-2021)
11.1.5 Amneal Pharmaceuticals Recent Development
11.2 Arbor Pharmaceuticals
11.2.1 Arbor Pharmaceuticals Company Details
11.2.2 Arbor Pharmaceuticals Business Overview
11.2.3 Arbor Pharmaceuticals Perinatal Infections Treatment Introduction
11.2.4 Arbor Pharmaceuticals Revenue in Perinatal Infections Treatment Business (2016-2021)
11.2.5 Arbor Pharmaceuticals Recent Development
11.3 Par Pharmaceutical
11.3.1 Par Pharmaceutical Company Details
11.3.2 Par Pharmaceutical Business Overview
11.3.3 Par Pharmaceutical Perinatal Infections Treatment Introduction
11.3.4 Par Pharmaceutical Revenue in Perinatal Infections Treatment Business (2016-2021)
11.3.5 Par Pharmaceutical Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Perinatal Infections Treatment Introduction
11.4.4 Mylan Revenue in Perinatal Infections Treatment Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Perinatal Infections Treatment Introduction
11.5.4 GSK Revenue in Perinatal Infections Treatment Business (2016-2021)
11.5.5 GSK Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Perinatal Infections Treatment Introduction
11.6.4 Novartis Revenue in Perinatal Infections Treatment Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Details
11.7.2 Sun Pharmaceutical Business Overview
11.7.3 Sun Pharmaceutical Perinatal Infections Treatment Introduction
11.7.4 Sun Pharmaceutical Revenue in Perinatal Infections Treatment Business (2016-2021)
11.7.5 Sun Pharmaceutical Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Perinatal Infections Treatment Introduction
11.8.4 Teva Pharmaceutical Revenue in Perinatal Infections Treatment Business (2016-2021)
11.8.5 Teva Pharmaceutical Recent Development
11.9 Hikma Pharmaceuticals
11.9.1 Hikma Pharmaceuticals Company Details
11.9.2 Hikma Pharmaceuticals Business Overview
11.9.3 Hikma Pharmaceuticals Perinatal Infections Treatment Introduction
11.9.4 Hikma Pharmaceuticals Revenue in Perinatal Infections Treatment Business (2016-2021)
11.9.5 Hikma Pharmaceuticals Recent Development
11.10 ViiV Healthcare
11.10.1 ViiV Healthcare Company Details
11.10.2 ViiV Healthcare Business Overview
11.10.3 ViiV Healthcare Perinatal Infections Treatment Introduction
11.10.4 ViiV Healthcare Revenue in Perinatal Infections Treatment Business (2016-2021)
11.10.5 ViiV Healthcare Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Perinatal Infections Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Antiviral
Table 4. Global Perinatal Infections Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Perinatal Infections Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Perinatal Infections Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Perinatal Infections Treatment Market Share by Regions (2016-2021)
Table 8. Global Perinatal Infections Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Perinatal Infections Treatment Market Share by Regions (2022-2027)
Table 10. Perinatal Infections Treatment Market Trends
Table 11. Perinatal Infections Treatment Market Drivers
Table 12. Perinatal Infections Treatment Market Challenges
Table 13. Perinatal Infections Treatment Market Restraints
Table 14. Global Perinatal Infections Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Perinatal Infections Treatment Market Share by Players (2016-2021)
Table 16. Global Top Perinatal Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Perinatal Infections Treatment as of 2020)
Table 17. Ranking of Global Top Perinatal Infections Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Perinatal Infections Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Perinatal Infections Treatment Product Solution and Service
Table 21. Date of Enter into Perinatal Infections Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Perinatal Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Perinatal Infections Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Perinatal Infections Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Perinatal Infections Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Perinatal Infections Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Perinatal Infections Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Perinatal Infections Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Perinatal Infections Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Perinatal Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Perinatal Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Perinatal Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Perinatal Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Perinatal Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Perinatal Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Perinatal Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Perinatal Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Perinatal Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Perinatal Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Perinatal Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Perinatal Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Perinatal Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Perinatal Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Perinatal Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Perinatal Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Perinatal Infections Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Perinatal Infections Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Perinatal Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Perinatal Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Perinatal Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Perinatal Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Perinatal Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Perinatal Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Perinatal Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Perinatal Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Perinatal Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Perinatal Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Perinatal Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Perinatal Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Amneal Pharmaceuticals Company Details
Table 62. Amneal Pharmaceuticals Business Overview
Table 63. Amneal Pharmaceuticals Perinatal Infections Treatment Product
Table 64. Amneal Pharmaceuticals Revenue in Perinatal Infections Treatment Business (2016-2021) & (US$ Million)
Table 65. Amneal Pharmaceuticals Recent Development
Table 66. Arbor Pharmaceuticals Company Details
Table 67. Arbor Pharmaceuticals Business Overview
Table 68. Arbor Pharmaceuticals Perinatal Infections Treatment Product
Table 69. Arbor Pharmaceuticals Revenue in Perinatal Infections Treatment Business (2016-2021) & (US$ Million)
Table 70. Arbor Pharmaceuticals Recent Development
Table 71. Par Pharmaceutical Company Details
Table 72. Par Pharmaceutical Business Overview
Table 73. Par Pharmaceutical Perinatal Infections Treatment Product
Table 74. Par Pharmaceutical Revenue in Perinatal Infections Treatment Business (2016-2021) & (US$ Million)
Table 75. Par Pharmaceutical Recent Development
Table 76. Mylan Company Details
Table 77. Mylan Business Overview
Table 78. Mylan Perinatal Infections Treatment Product
Table 79. Mylan Revenue in Perinatal Infections Treatment Business (2016-2021) & (US$ Million)
Table 80. Mylan Recent Development
Table 81. GSK Company Details
Table 82. GSK Business Overview
Table 83. GSK Perinatal Infections Treatment Product
Table 84. GSK Revenue in Perinatal Infections Treatment Business (2016-2021) & (US$ Million)
Table 85. GSK Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Perinatal Infections Treatment Product
Table 89. Novartis Revenue in Perinatal Infections Treatment Business (2016-2021) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Sun Pharmaceutical Company Details
Table 92. Sun Pharmaceutical Business Overview
Table 93. Sun Pharmaceutical Perinatal Infections Treatment Product
Table 94. Sun Pharmaceutical Revenue in Perinatal Infections Treatment Business (2016-2021) & (US$ Million)
Table 95. Sun Pharmaceutical Recent Development
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Revenue in Perinatal Infections Treatment Business (2016-2021) & (US$ Million)
Table 99. Teva Pharmaceutical Recent Development
Table 100. Hikma Pharmaceuticals Company Details
Table 101. Hikma Pharmaceuticals Business Overview
Table 102. Hikma Pharmaceuticals Perinatal Infections Treatment Product
Table 103. Hikma Pharmaceuticals Revenue in Perinatal Infections Treatment Business (2016-2021) & (US$ Million)
Table 104. Hikma Pharmaceuticals Recent Development
Table 105. ViiV Healthcare Company Details
Table 106. ViiV Healthcare Business Overview
Table 107. ViiV Healthcare Perinatal Infections Treatment Product
Table 108. ViiV Healthcare Revenue in Perinatal Infections Treatment Business (2016-2021) & (US$ Million)
Table 109. ViiV Healthcare Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Perinatal Infections Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Antiviral Features
Figure 4. Global Perinatal Infections Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Perinatal Infections Treatment Report Years Considered
Figure 9. Global Perinatal Infections Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Perinatal Infections Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Perinatal Infections Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Perinatal Infections Treatment Market Share by Regions (2022-2027)
Figure 13. Global Perinatal Infections Treatment Market Share by Players in 2020
Figure 14. Global Top Perinatal Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Perinatal Infections Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Perinatal Infections Treatment Revenue in 2020
Figure 16. Global Perinatal Infections Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Perinatal Infections Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Perinatal Infections Treatment Market Share by Type (2016-2027)
Figure 20. North America Perinatal Infections Treatment Market Share by Application (2016-2027)
Figure 21. North America Perinatal Infections Treatment Market Share by Country (2016-2027)
Figure 22. United States Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Perinatal Infections Treatment Market Share by Type (2016-2027)
Figure 26. Europe Perinatal Infections Treatment Market Share by Application (2016-2027)
Figure 27. Europe Perinatal Infections Treatment Market Share by Country (2016-2027)
Figure 28. Germany Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Perinatal Infections Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Perinatal Infections Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Perinatal Infections Treatment Market Share by Region (2016-2027)
Figure 38. China Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Perinatal Infections Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Perinatal Infections Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Perinatal Infections Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Perinatal Infections Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Perinatal Infections Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Perinatal Infections Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Perinatal Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Amneal Pharmaceuticals Revenue Growth Rate in Perinatal Infections Treatment Business (2016-2021)
Figure 58. Arbor Pharmaceuticals Revenue Growth Rate in Perinatal Infections Treatment Business (2016-2021)
Figure 59. Par Pharmaceutical Revenue Growth Rate in Perinatal Infections Treatment Business (2016-2021)
Figure 60. Mylan Revenue Growth Rate in Perinatal Infections Treatment Business (2016-2021)
Figure 61. GSK Revenue Growth Rate in Perinatal Infections Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Perinatal Infections Treatment Business (2016-2021)
Figure 63. Sun Pharmaceutical Revenue Growth Rate in Perinatal Infections Treatment Business (2016-2021)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Perinatal Infections Treatment Business (2016-2021)
Figure 65. Hikma Pharmaceuticals Revenue Growth Rate in Perinatal Infections Treatment Business (2016-2021)
Figure 66. ViiV Healthcare Revenue Growth Rate in Perinatal Infections Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の淋菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Neisseria Gonorrhoeae Infections Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4560 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、淋菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他）、用途別市場規模（クリニック、病院、その他）、主要地...

世界の人工関節感染症治療市場規模・現状・予測（2021年-2027年）

Global Prosthetic Joint Infections Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4776 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、人工関節感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界の急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療市場規模・現状・予測（2021年-2027年）

Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3756 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（デラフロキサシン、バンコマイシン、セフタロリンフォサミル、その他）、用途別市場規模（蜂巣炎、膿瘍、外科...

世界の気道感染症（RTI）治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Tract infections (RTIs) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4818 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、気道感染症（RTI）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、錠剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年）

Global Meningococcal Infections Vaccine Market Size, Status and Forecast 2021-2027
QFJ1-4491 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、髄膜炎菌感染症ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（4価（血清型A＆C＆W-135＆Y）、2価（血清型C＆Y）、血清型A、血清型B、血清型X）、用途別市場規模（病院、クリニック）、主...

世界の副甲状腺機能低下症治療市場規模・現状・予測（2021年-2027年）

Global Hypoparathyroidism Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4341 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、副甲状腺機能低下症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の周期性四肢麻痺治療市場規模・現状・予測（2021年-2027年）

Global Periodic Paralysis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4683 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、周期性四肢麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベータ遮断薬、炭酸脱水酵素阻害薬、その他）、用途別市場規模（低カリウム血症性周期性四肢麻痺、高カリウム血症性周期性四肢麻痺、甲状腺毒性...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の非びらん性胃食道逆流症治療市場規模・現状・予測（2021年-2027年）

Global Nonerosive Reflux Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5889 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、非びらん性胃食道逆流症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロトンポンプ阻害剤、H2受容体拮抗薬、制酸剤、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、主要地域別市場...

世界の女性化乳房治療市場規模・現状・予測（2021年-2027年）

Global Gynecomastia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4275 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、女性化乳房治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術治療）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の人工関節感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prosthetic Joint Infections Treatment Market The global Prosthetic Joint Infections Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
世界の淋菌感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Neisseria Gonorrhoeae Infections Treatment Market The global Neisseria Gonorrhoeae Infections Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…
世界の気道感染症（RTI）治療市場規模・現状・予測（2021年-2027年） Respiratory Infections Treatment can affect the sinuses, throat, airways or lungs. Market Analysis and Insights: Global Respiratory Tract infections (RTIs) Treatment Market The global Respiratory Tract infections (RTIs) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX …
世界の急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療市場規模・現状・予測（2021年-2027年） According to market experts acute skin and skin structure infections (ABSSSI) comprise set of bacterial infections that involve multiple layers of the skin and associated tissues. These infections tend to be more severe in nature than simple infections of the skin, and they usually require systemic …
世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年） Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in…